Skip to main content
Top
Published in: Cancer Causes & Control 3/2016

01-03-2016 | Brief report

Breast and cervical cancer screening among Hispanic subgroups in the USA: estimates from the National Health Interview Survey 2008, 2010, and 2013

Authors: Meredith L. Shoemaker, Mary C. White

Published in: Cancer Causes & Control | Issue 3/2016

Login to get access

Abstract

Purpose

This study examined patterns in mammography and Pap test use across and within subpopulations of Hispanic women.

Methods

Based on data from the National Health Interview Survey (2008, 2010, and 2013), we estimated the proportion of Hispanic women reporting testing for breast and cervical cancer for specific subgroups. We examined test use by demographic characteristics using Chi-square tests.

Results

Overall, the proportion of women aged 50–74 years who reported a mammogram within the past 2 years did not differ significantly across Hispanic subgroups. Among publically and uninsured women, however, proportions of mammography utilization varied significantly across Hispanic subgroups. The proportion of women aged 21–65 years who received a Pap test within the past 3 years differed significantly across Hispanic subgroups.

Conclusions

Among subgroups of Hispanic women, patterns in mammography and Pap test use vary by insurance status, length of US residency, and type of screening. Certain subgroups of Hispanic women may benefit from culturally tailored efforts to promote breast and cervical cancer screening.
Literature
2.
go back to reference Sabatino SA, White MC, Thompson TD, Klabunde CN (2015) Cancer screening test use—United States, 2013. MMWR Morb Mortal Wkly Rep 64:464–468PubMed Sabatino SA, White MC, Thompson TD, Klabunde CN (2015) Cancer screening test use—United States, 2013. MMWR Morb Mortal Wkly Rep 64:464–468PubMed
3.
go back to reference Dominguez K, Penman-Aguilar A, Chang MH, Moonesinghe R, Castellanos T, Rodriguez-Lainz A, Schieber R (2015) Vital signs: leading causes of death, prevalence of diseases and risk factors, and use of health services among Hispanics in the United States—2009–2013. MMWR Morb Mortal Wkly Rep 64:469–478PubMed Dominguez K, Penman-Aguilar A, Chang MH, Moonesinghe R, Castellanos T, Rodriguez-Lainz A, Schieber R (2015) Vital signs: leading causes of death, prevalence of diseases and risk factors, and use of health services among Hispanics in the United States—2009–2013. MMWR Morb Mortal Wkly Rep 64:469–478PubMed
4.
go back to reference Cokkinides VE, Bandi P, Siegel RL, Jemal A (2012) Cancer-related risk factors and preventive measures in US Hispanics/Latinos. CA Cancer J Clin 62:353–363CrossRefPubMed Cokkinides VE, Bandi P, Siegel RL, Jemal A (2012) Cancer-related risk factors and preventive measures in US Hispanics/Latinos. CA Cancer J Clin 62:353–363CrossRefPubMed
5.
go back to reference Parsons VL, Moriarity C, Jonas K, Moore TF, Davis KE, Tompkins L (2014) Design and estimation for the National Health Interview Survey, 2006–2015. Vital Health Stat 2(165):1–53 Parsons VL, Moriarity C, Jonas K, Moore TF, Davis KE, Tompkins L (2014) Design and estimation for the National Health Interview Survey, 2006–2015. Vital Health Stat 2(165):1–53
7.
go back to reference Rosales M, Gonzalez P (2013) Mammography screening among Mexican, Central-American, and South-American women. J Immigr Minor Health 15:225–233CrossRefPubMed Rosales M, Gonzalez P (2013) Mammography screening among Mexican, Central-American, and South-American women. J Immigr Minor Health 15:225–233CrossRefPubMed
8.
go back to reference Smith JL, Wilson KM, Orians CE, Byrd TL (2013) AMIGAS: building a cervical cancer screening intervention for public health practice. J Womens Health (Larchmt) 22:718–723CrossRef Smith JL, Wilson KM, Orians CE, Byrd TL (2013) AMIGAS: building a cervical cancer screening intervention for public health practice. J Womens Health (Larchmt) 22:718–723CrossRef
Metadata
Title
Breast and cervical cancer screening among Hispanic subgroups in the USA: estimates from the National Health Interview Survey 2008, 2010, and 2013
Authors
Meredith L. Shoemaker
Mary C. White
Publication date
01-03-2016
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 3/2016
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-016-0718-5

Other articles of this Issue 3/2016

Cancer Causes & Control 3/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine